UC San Diego Health has become the first in the U.S. to offer a new blood test for testicular cancer. The test measures the biomarker microRNA-371a-3P, which predicts the presence of testicular cancer cells with 90% accuracy, according to a…
The Latest
Michael Kastan, MD, PhD, is stepping down as executive director of the Duke Cancer Institute, a position he has held since 2011. The Duke Cancer Institute is part of Durham, N.C.-based Duke University Health System. Dr. Kastan is the inaugural…
Miami-based Sylvester Comprehensive Cancer Center has launched the Sylvester Survivorship and Supportive Care Institute. Frank Penedo, PhD, will serve as the institute’s director alongside Carmen Calfa, MD, as co-director and medical director, according to an Oct. 30 news release from…
Boston-based Dana-Farber Cancer Institute received a $78 million gift from the Pan-Mass Challenge, an annual bike-a-thon across Massachusetts. Since its foundation in 1980, the event has raised $1.125 billion for Dana-Farber, according to a Nov. 2 news release from the…
Oncologists are grappling with chemotherapy drug shortages, which have led many to make difficult triage decisions on which patients receive the drugs first, Medscape Medical News reported Nov. 3. Chemotherapy drugs are among the top five drug classes with active…
Not every critical innovation in cancer care comes from a Phase III trial or a new drug approval. Sometimes, progress comes from a new onboarding curriculum that improves how nurses acclimate to a high-acuity unit. It could come from a…